openPR Logo
Press release

IVD Assay Development Market Growth Outlook (2025-2032) | Meticulous Research®

11-14-2025 06:23 AM CET | Health & Medicine

Press release from: Meticulous Research®

IVD Assay Development Market Growth Outlook (2025-2032) |

The global IVD assay development market continues to grow rapidly as healthcare systems worldwide shift toward early diagnosis, precision medicine, and advanced molecular testing. Valued at USD 4.93 billion in 2024, the market is projected to reach USD 9.15 billion by 2032, rising from an estimated USD 5.31 billion in 2025 at a CAGR of 8.1%. The expansion of this industry is fueled by the increasing prevalence of chronic diseases, the fast-growing elderly population, the heavy burden of infectious diseases, and ongoing innovations in diagnostic technologies. In addition, rising healthcare expenditures and expanding opportunities in emerging economies are helping accelerate the growth of IVD assay development services.

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=6037

Rising Chronic Diseases and Aging Population Strengthen Market Growth

Chronic diseases such as diabetes, cancer, heart disease, and arthritis are growing at alarming rates across the world. According to the World Health Organization, chronic conditions cause more than 41 million deaths annually, representing nearly three-quarters of global mortality. Changing lifestyles, unhealthy eating habits, tobacco use, and increasing physical inactivity continue to worsen the overall disease burden. The number of individuals living with diabetes is expected to grow from 537 million in 2021 to 643 million by 2030 and 783 million by 2045, according to the International Diabetes Federation.

A significant contributor to this rise is the rapidly aging global population. People aged 65 years and older now represent one of the fastest-growing demographic groups. As per the United Nations, the elderly population is expected to account for 16% of the global population by 2050, compared to 10% in 2022. With age, the body's immune system weakens and the risk of chronic illnesses increases. The growing number of elderly individuals naturally boosts the demand for diagnostic tests, thereby creating new opportunities for IVD assay development. Cancer cases also continue to rise sharply; WHO estimates that new cancer cases will increase from 19.2 million in 2022 to 24.1 million in 2030. This growing disease burden is compelling diagnostic companies to expand their assay development capabilities to meet the increasing demand for fast and accurate testing.

High Burden of Infectious Diseases Driving Need for Reliable Diagnostics

Infectious diseases remain one of the world's major health challenges, driven by viruses, bacteria, fungi, and parasites. The need for quick, precise, and scalable diagnostics has increased significantly as outbreaks intensify. The global burden of HIV in 2023 stood at 39.9 million individuals, while hepatitis B and C continue to affect hundreds of millions worldwide. Outbreaks from zoonotic diseases such as Ebola and monkeypox have also increased dramatically in the last decade. The COVID-19 pandemic further highlighted the critical importance of reliable diagnostic assays, with over 767 million confirmed cases reported by mid-2023.

Other infectious threats, such as sepsis and tuberculosis, continue to claim millions of lives each year. Rising infectious disease cases worldwide are expected to significantly accelerate demand for IVD assay development services, as healthcare systems prioritize early detection to reduce mortality and prevent widespread outbreaks.

Browse in Depth : https://www.meticulousresearch.com/product/ivd-assay-development-market-6037

Why Are IVD Assay Development Services Becoming Essential for Diagnostic Companies?

Answer: IVD assay development services have become essential because diagnostic companies are facing increasing demand for accurate, rapid, and scalable diagnostic solutions. Outsourcing assay development helps companies reduce production costs, shorten time-to-market, access advanced technologies, and meet regulatory requirements more efficiently. As new diseases continue to emerge and precision medicine becomes mainstream, many manufacturers rely on specialized assay development partners to support innovation and higher testing volumes.

Advanced Technologies Unlock New Opportunities in Assay Development

Technological innovations are reshaping the IVD landscape, with platforms such as PCR, ELISA, CLIA, next-generation sequencing, and proteomics driving major advancements. These technologies enable precise detection of biomarkers, genetic mutations, and disease signatures. The rise of genomic testing has pushed the industry toward personalized medicine, where diagnostic assays are designed to match a patient's unique genetic profile.

Next-generation sequencing provides deep insights into the human genome and is being increasingly used for cancer profiling, drug resistance testing, and early disease detection. High-throughput sequencing has further accelerated research by analyzing millions of DNA molecules simultaneously, improving accuracy, turnaround times, and data quality. These advancements are paving the way for new assay formats and improved diagnostic solutions.

Recent developments highlight this trend. In 2024, Seegene partnered with Springer Nature to fund PCR assay development, while SpinChip Diagnostics raised significant capital to support clinical studies and develop novel diagnostic assays. Companies continue to invest heavily in new technologies to strengthen their assay pipelines.

Segment Insights and Market Dynamics

Among offerings, IVD assay development services accounted for the largest market share in 2024. This dominance is due to growing outsourcing trends, high demand for assays in drug discovery, and increasing collaborations between diagnostic manufacturers and research institutions. IVD stability testing, however, is expected to grow the fastest during the forecast period as companies prioritize product accuracy and reliability.

Immunoassay and immunochemistry technologies dominated the market in 2024, driven by their widespread use in infectious disease testing and chronic disease diagnostics. Infectious diseases remained the largest application segment, reflecting the continuing global burden of viral and bacterial infections.

Buy the Complete Report with an Impressive Discount: https://www.meticulousresearch.com/view-pricing/1354

Regional Landscape and Future Opportunities

North America led the IVD assay development market in 2024, supported by strong healthcare infrastructure, a high prevalence of chronic and infectious diseases, and the presence of leading technology providers. However, Asia-Pacific is anticipated to record the fastest growth, driven by rising healthcare investments, expanding middle-class populations, and increasing adoption of modern diagnostic technologies.

Related Reports:

Côte d'Ivoire IVD Market: https://www.meticulousresearch.com/product/c%C3%B4te-d%E2%80%99Ivoire-ivd-market-6135
Europe IVD Market : https://www.meticulousresearch.com/product/europe-ivd-market-5718
Asia-Pacific IVD Market : https://www.meticulousresearch.com/product/asia-pacific-ivd-market-5750

About Us:

We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with actionable market intelligence tailored to drive revenue transformation and strategic growth. Our insights reveal forward-looking revenue opportunities, providing our clients with a competitive edge through a diverse suite of research solutions-syndicated reports, custom research, and direct analyst engagement.

Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight key industry sectors and 20+ geographic markets. With a focus on solving the complex challenges facing global business leaders, our research enables informed decision-making that propels sustainable growth and operational excellence. We are dedicated to delivering high-impact solutions that transform business performance and fuel innovation in the competitive global marketplace.

Contact Us:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IVD Assay Development Market Growth Outlook (2025-2032) | Meticulous Research® here

News-ID: 4270260 • Views:

More Releases from Meticulous Research®

Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticulous Research®
Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticul …
The nutraceutical products market is witnessing steady and significant growth, driven by a rising awareness of health, nutrition, and disease prevention. Between 2023 and 2030, the market is projected to expand at a compound annual growth rate of 7.8%, ultimately reaching a value of $691.87 billion by the end of the forecast period. This growth reflects a major shift in consumer mindset, as individuals increasingly seek products that offer both
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insig …
The way we feed our livestock is changing, and feed additives are at the heart of that transformation. Over the next decade, the global feed additives market is expected to surpass $51 billion, fueled by rising demand for meat and dairy products, concerns over animal health, and a push toward more sustainable farming practice. Farmers today are no longer just feeding animals they are strategically nourishing them to improve growth,
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | Meticulous Research®
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | M …
The home medical equipment market is growing steadily and is projected to reach nearly $63 billion by 2030. These devices are designed to help people manage their health at home, allowing patients to remain independent while receiving the care they need. From respiratory devices to mobility aids, these products make it possible for individuals to maintain a better quality of life without relying entirely on hospital care. They are especially
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regi …
The membrane filtration technologies market is steadily expanding, with expectations to hit $22.2 billion by 2030. Over the past few years, industries and municipalities alike have faced increasing pressure to manage water more efficiently. Water scarcity, environmental regulations, and operational needs have created a situation where traditional water treatment methods are no longer sufficient. Businesses are turning toward membrane filtration technologies as a solution that offers both reliability and precision. Water

All 5 Releases


More Releases for IVD

Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025? The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is